Inotiv (NOTV) to Release Earnings on Friday

Inotiv (NASDAQ:NOTV) will release its earnings data before the market opens on Friday, May 10th. Analysts expect Inotiv to post earnings of $0.05 per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Inotiv (NASDAQ:NOTV) last released its quarterly earnings results on Wednesday, February 7th. The company reported ($0.60) earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.67). The firm had revenue of $135.50 million during the quarter, compared to the consensus estimate of $136.26 million. Inotiv had a negative return on equity of 10.99% and a negative net margin of 5.67%. On average, analysts expect Inotiv to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Inotiv Trading Down 1.3 %

Inotiv stock opened at $4.71 on Wednesday. The stock has a market cap of $121.47 million, a P/E ratio of -3.62 and a beta of 3.37. Inotiv has a fifty-two week low of $1.61 and a fifty-two week high of $11.42. The firm’s fifty day moving average price is $7.26 and its 200-day moving average price is $4.72. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.28 and a current ratio of 1.74.

Analyst Ratings Changes

Separately, Jefferies Financial Group raised shares of Inotiv from a “hold” rating to a “buy” rating and upped their price target for the stock from $3.00 to $11.50 in a report on Friday, February 9th.

Inotiv Company Profile

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.